ARAshley Elizabeth Ross

Ashley Elizabeth Ross

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashley Elizabeth Ross has a total of 131 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Guanosine contributes to rapid purinergic regulation of dopamine during ischemia

    by Moriah E. Weese-Myers, Alaa S. Abdelrazeq Hassan, Ashley E. Ross

    Purinergic modulation of neurotransmission is a primary strategy employed in rapid neuroprotection during and after ischemic stroke. While the contributions of adenosine and ATP to the purinome are well-documented, guanosine-based regulatory activity has remained under-investigated. In the ischemia-vulnerable CA1 region of the hippocampus, dopamine serves as both a neurotransmitter involved in long-term potentiation during memory acquisition and as a regulator focused on modulating glutamate activity. Dopamine has been suggested as a potential protective force against glutamate-induced excitotoxicity in early ischemia. Here, we investigate changes in dopamine signaling during ischemia and demonstrate that guanosine administration during injury has an immediate protective effect. We observe rapid suppression of dopamine release following ischemic insult that is completely restored with administration of a low micromolar dose of guanosine. Changes in dopamine signaling and short-term mRNA production further suggest that guanosine’s rapid regulatory role may be partially achieved through the adenosine A1 and A2a receptors and that it facilitates dopamine reuptake through the dopamine transporter DAT. We present the first evidence that guanosine plays a rapid regulatory role in dopamine neurotransmission and that it may function as a broad facilitator of neurotransmitter reuptake, diversifying our understanding of the purinome in ischemia.

  • Open Access

    Optimization of Subsecond Estradiol Detection through Analysis of Surface–Analyte Interactions

    by Moriah E. Weese-Myers, Vivek Subedi, Naimah El-Amin, Faith Idahosa, Manisha Fowler, Ashley E. Ross

    Subsecond neurochemical signaling is the fastest and one of the most diverse forms of intercellular communication employed along the neuro-immune-endocrine axis; consequently, spatiotemporally resolved approaches with high sensitivity and selectivity tailored to specific analytes are required for adequate monitoring. However, many existing electrochemical approaches are optimized solely towards catecholamine and indolamine detection, leaving a wide array of structurally diverse neuroregulators at a disadvantage with limited detection capability. Here, we use estradiola fast-signaling neurosteroid vital for neuroprotection that has proven difficult to detect with existing methodsas a model target analyte for optimizing direct electrochemical detection at carbon surfaces. We take a two-pronged approach to optimizing estradiol detection by examining the electrode-analyte interface from the perspective of both the carbon surface and the target molecule. We first establish the surface characteristics of diverse carbon fibers, then examine estradiol’s electrochemical behavior at each surface. Finally, we determine the contributions of estradiol’s structure to specific adsorption, elucidating subtle structural considerations to analyte-specific tailoring of carbon electrodes. By taking this multi-perspective approach, we develop a thorough understanding of the interactions between carbon sensing surfaces and estradiol for improved sensitivity and selectivity. Moreover, our approach is applicable to other neglected neurochemicals that have proven challenging to detect. This work creates a potentially broadly applicable roadmap for customizing direct monitoring at carbon surfaces through a tailored approach to optimizing the electrode-analyte interface.

  • Open Access

    Engineering localized injury: a 3D microfluidic platform approach for ex vivo tissue interrogation

    by Colby E. Witt, Lauren M. Delong, Maria K. Kristinsdottir, Alexandra K. Brooke, Ashley E. Ross

    Over the years, interrogating and replicating biological events ex vivo and in vitro has proven to provide a breadth of knowledge into various mechanisms of diseases; however, there remains a challenge in understanding the onset of disease within tonic, localized environments over time. Microfluidics provides an alternative approach that can be coupled with many methods to better replicate specific localized and prolonged biological events. In this work, we introduce a novel 3D-printed device that significantly improves upon previous microfluidic approaches aimed at maintaining high spatial resolution and sustainment of delivery, ultimately enabling us to examine localized injuries within an ex vivo model with higher precision and control. This work focuses on focal ischemia; however, it should be noted that the device is applicable to any event that needs high spatial resolution and sustained fluidic delivery. We demonstrate that tissue remains viable on this platform and that we are capable of achieving exquisite fluidic control, not affordable from standard lithographic techniques. Additionally, we incorporate real-time neurochemical monitoring to demonstrate rapid and robust changes in dopamine signaling at the site of focal ischemia, further validating our platform for localized injury studies. This device fills a critical gap in the existing literature by significantly improving upon the capabilities of localized tissue stimulation and further enhances our understanding of local physiological changes during ischemic events, providing a critical advance in biomedical tools for measuring at localized regions within tissue. Graphical Abstract

  • α2-Adrenergic modulation of neuroimmune interactions differs between the spleen and mesenteric lymph nodes

    by Alexandra K Brooke, Daniel P Murrow, Kaejaren C N Caldwell, Sarbeshwar Ojha, Colby E Witt, Steve Davidson, Ashley E Ross

    The sympathetic nervous system modulates immune responses through the release of norepinephrine (NE), yet the dynamics of this signaling differ across lymphoid organs. In this study, we investigated how NE release and α2-adrenergic receptor (α2AR) modulation influence neuroimmune interactions in the spleen and mesenteric lymph nodes (MLNs), 2 secondary lymphoid tissues with distinct innervation patterns. Using fast-scan cyclic voltammetry (FSCV), we found that the spleen exhibited more frequent and higher-amplitude NE events than the MLNs, consistent with its denser sympathetic innervation. Pharmacological manipulation of α2ARs revealed that yohimbine hydrochloride, an α2AR antagonist, increased NE release in both organs, while dexmedetomidine hydrochloride, an α2AR agonist, suppressed it, often below detection thresholds. Complementary 3D immunohistochemistry demonstrated tissue- and cell type–specific changes in immune cell proximity to neuronal structures following adrenergic modulation, with T cells and B cells displaying distinct spatial reorganization. These findings highlight that α2AR signaling fine-tunes NE release and immune cell localization in a context-dependent manner, influenced by organ-specific architecture and innervation. Our results underscore the importance of dynamic local neuroimmune interactions in immune regulation and suggest potential therapeutic opportunities for targeting adrenergic signaling in inflammatory and autoimmune diseases.


  • Oligopeptides and Polypeptides Impact Norepinephrine Detection in Lymphoid Tissue

    by Sarbeshwar Ojha, Alexandra K. Brooke, Blaise J. Ostertag, Daniel P. Murrow, Colby E. Witt, Ashley E. Ross

    Detection of neurochemicals voltammetrically can be challenging in complex matrices like tissue. Norepinephrine (NE) is a neurotransmitter in the brain and is directly released by the sympathetic nervous system in the periphery. Fast-scan cyclic voltammetry (FSCV) is an electrochemical technique previously used to detect NE from sympathetic neurons in lymphoid tissues. Mesenteric lymph nodes present a unique challenge to FSCV due to their complex tissue matrix, which includes immune cells and neurons. These cells release various neuropeptides, cytokines, and other chemical signaling molecules, which can interfere with FSCV. Notably, Neuropeptide Y (NPY) from sympathetic neurons, and Substance P (SubP) and Calcitonin Gene-Related Peptide (CGRP) from sensory neurons are common peptides that are released locally near NE sites. These peptides are regulated by and interact with NE through complex neuronal circuits, potentially impacting FSCV NE detection. We demonstrate that increasing levels of each peptide alter voltammetric NE detection. We observed that the NE oxidation potential shifts with each peptide in vitro, and NE cyclic voltammograms exhibit unique peak broadening specific to NPY compared to SubP and CGRP, indicating that each peptide affects the carbon fiber microelectrode (CFME) differently. Overall, we show significant convolution of voltammetric NE peaks in the presence of peptides, providing evidence that future developments in materials to reduce protein fouling could significantly improve the robustness and accuracy of NE FSCV detection.

  • Purinergic Receptor P2Y1 Modulates Catecholamine Signaling in Murine Mesenteric Lymph Nodes

    by Alexandra K. Brooke, Sarbeshwar Ojha, Daniel P. Murrow, Ashley E. Ross

    Neuroimmune communication is crucial for the body's response to physiological challenges, homeostasis, and immune stress response. Adrenergic and purinergic neurotransmission in the sympathetic nervous system is vital for this communication. This study achieves the first co-detection of adenine-based purines and catecholamines in mesenteric lymph nodes via fast-scan cyclic voltammetry. Additionally, we reveal that manipulating an ATP receptor can impact catecholamine signaling in the lymph node for the first time. The G-protein-coupled receptor P2Y1, which controls intracellular Ca2+ levels, was targeted with the antagonist MRS2179. MRS2179 decreased catecholamine concentrations, increased inter-event times, and prolonged event durations. These results suggest that events became smaller, less frequent, and longer-lasting, possibly attributable to decreased intracellular Ca2+ levels. These findings indicate that ATP release in the lymph node can partially regulate norepinephrine signaling, providing mechanistic insight into sympathetic neuronal neurotransmitter control. A deeper understanding of more complicated neuroimmune mechanisms could potentially influence the development of therapeutic strategies in immunology and neurobiology.


  • New approach to control ischemic severity ex vivo

    by Bindu Modi, Kaejaren C.N. Caldwell, Colby E. Witt, Moriah E. Weese-Myers, Ashley E. Ross

  • Open Access

    Plasma-treated gold microelectrodes for subsecond detection of Zn(ii) with fast-scan cyclic voltammetry

    by Anntonette N. Perry, Romana Jarosova, Colby E. Witt, Moriah E. Weese-Myers, Vivek Subedi, Ashley E. Ross

    O2-plasma treated gold microelectrodes enable sensitive and selective detection of Zn(ii) with high spatiotemporal resolution.


  • Surface-Roughened Graphene Oxide Microfibers Enhance Electrochemical Reversibility

    by Blaise J. Ostertag, Evan J. Porshinsky, Chaminda P. Nawarathne, Ashley E. Ross

    Here, we provide an optimized method for fabricating surface-roughened graphene oxide disk microelectrodes (GFMEs) with enhanced defect density to generate a more suitable electrode surface for dopamine detection with fast-scan cyclic voltammetry (FSCV). FSCV detection, which is often influenced by adsorption-based surface interactions, is commonly impacted by the chemical and geometric structure of the electrode's surface, and graphene oxide is a tunable carbon-based nanomaterial capable of enhancing these two key characteristics. Synthesized GFMEs possess exquisite electronic and mechanical properties. We have optimized an applied inert argon (Ar) plasma treatment to increase defect density, with minimal changes in chemical functionality, for enhanced surface crevices to momentarily trap dopamine during detection. Optimal Ar plasma treatment (100 sccm, 60 s, 100 W) generates crevice depths of 33.4 ± 2.3 nm with high edge plane character enhancing dopamine interfacial interactions. Increases in GFME surface roughness improve electron transfer rates and limit diffusional rates out of the crevices to create nearly reversible dopamine electrochemical redox interactions. The utility of surface-roughened disk GFMEs provides comparable detection sensitivities to traditional cylindrical carbon fiber microelectrodes while improving temporal resolution ten-fold with amplified oxidation current due to dopamine cyclization. Overall, surface-roughened GFMEs enable improved adsorption interactions, momentary trapping, and current amplification, expanding the utility of GO microelectrodes for FSCV detection.